Females, Aging, Metabolism, and Exercise

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Obesity
Interventions
DRUG

GnRH agonist

"Drug: leuprolide acetate~Other Names:~Lupron 3.75 mg for depot suspension delivered by monthly intramuscular injection for 6 months"

BEHAVIORAL

Supervised cardiovascular exercise

Supervised exercise, 4 days per week for 45 to 60 minutes per session for 6 months

DRUG

Placebo

Placebo

Trial Locations (1)

80045

University of Colorado - Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Colorado, Denver

OTHER

NCT01712230 - Females, Aging, Metabolism, and Exercise | Biotech Hunter | Biotech Hunter